Kao YC

References (4)

Title : Longitudinal Multi-Domain Cognitive Assessment of Anti-Amyloid Monoclonal Antibodies Versus Acetylcholinesterase Inhibitors in Early Alzheimer's Disease: A Systematic Review and Meta-Analysis - Lee_2026_Geriatr.Gerontol.Int_26_e70492
Author(s) : Lee CY , Hsu TW , Kao YC , Tseng PT , Hsu CW , Lin YH , Liang CS
Ref : Geriatr Gerontol Int , 26 :e70492 , 2026
Abstract :
PubMedSearch : Lee_2026_Geriatr.Gerontol.Int_26_e70492
PubMedID: 41988809

Title : Cumulative cognitive benefits and brain volume change with anti-amyloid therapies for Alzheimer's disease - Lin_2026_J.Neurol.Neurosurg.Psychiatry__
Author(s) : Lin YH , Hsu TW , Kao YC , Thompson T , Carvalho AF , Stubbs B , Tseng PT , Hsu CW , Yang FC , Tsai CK , Yu CL , Liang CS , Tu YK
Ref : Journal of Neurology Neurosurg Psychiatry , : , 2026
Abstract :
PubMedSearch : Lin_2026_J.Neurol.Neurosurg.Psychiatry__
PubMedID: 41760397

Title : The efficacy and safety of anti-amyloid monoclonal antibody versus acetylcholinesterase inhibitor with an in-depth analysis across genotypes and disease stages: a systematic review and meta-analysis - Hsu_2025_J.Prev.Alzheimers.Dis__100195
Author(s) : Hsu CW , Hsu TW , Kao YC , Lin YH , Thompson T , Carvalho AF , Stubbs B , Tseng PT , Yang FC , Tsai CK , Yu CL , Tu YK , Liang CS
Ref : J Prev Alzheimers Dis , :100195 , 2025
Abstract :
PubMedSearch : Hsu_2025_J.Prev.Alzheimers.Dis__100195
PubMedID: 40316479

Title : Cognitive enhancers associated with decreased risk of injury in patients with dementia: a nationwide cohort study in Taiwan - Chao_2018_J.Investig.Med_66_684
Author(s) : Chao PC , Chien WC , Chung CH , Chu CW , Yeh CB , Huang SY , Lu RB , Chang HA , Kao YC , Yeh HW , Chiang WS , Chou YC , Tzeng NS
Ref : J Investig Med , 66 :684 , 2018
Abstract :
PubMedSearch : Chao_2018_J.Investig.Med_66_684
PubMedID: 29141875